Literature DB >> 33033146

Cardiovascular Family History Increases Risk for Late-Onset Adverse Cardiovascular Outcomes in Childhood Cancer Survivors: A St. Jude Lifetime Cohort Report.

Jason F Goldberg1, Kirsten K Ness2, Xiaofei Chi2, Aimee K Santucci2, Juan Carlos Plana3, Vijaya M Joshi4, Russell V Luepker5, Jean-Bernard Durand6, Robyn E Partin2, Rebecca M Howell7, Carmen L Wilson2, Jeffrey A Towbin4, John L Jefferies8, Deo Kumar Srivastava2, Melissa M Hudson2, Leslie L Robison2, Gregory T Armstrong2.   

Abstract

BACKGROUND: Survivors of childhood cancer have an increased risk of therapy-related cardiovascular disease. It is not known whether family history of cardiovascular disease further increases risk of adverse cardiovascular outcomes among survivors.
METHODS: Family history of cardiovascular disease was collected from 1,260 survivors [median age at diagnosis, 8 years (range, 0-23); age at last follow-up, 35 years (range, 18-66)] of childhood cancer in the St. Jude Lifetime Cohort Study. Multivariable risk models evaluated associations with cardiovascular disease (Common Terminology Criteria for Adverse Events grade 2-4 events) and cardiovascular risk factors.
RESULTS: Among survivors exposed to chest-directed radiation and/or anthracycline chemotherapy (n = 824), 7% reported a first-degree family history of heart failure, 19% myocardial infarction, 11% stroke, 26% atherosclerotic disease (myocardial infarction and/or stroke), 62% hypertension, and 31% diabetes mellitus. Eighteen percent of exposed survivors developed heart failure, 9% myocardial infarction, 3% stroke, 11% atherosclerotic disease, 30% hypertension, and 9% diabetes mellitus. Having a first-degree family history of atherosclerotic disease was independently associated with development of treatment-related heart failure [RR, 1.38; 95% confidence interval (CI), 1.01-1.88; P = 0.04] among exposed survivors. Risk for hypertension was increased among exposed survivors with a first-degree family history of hypertension (RR, 1.55; 95% CI, 1.26-1.92; P < 0.0001) or of any cardiovascular disease [myocardial infarction, stroke, or heart failure (RR, 1.30; 95% CI, 1.06-1.59; P = 0.01)].
CONCLUSIONS: Family history of cardiovascular disease and cardiovascular risk factors independently increased risk of heart failure and hypertension among survivors of childhood cancer exposed to cardiotoxic therapies. IMPACT: These data show the importance of cardiovascular family history as a risk factor for cardiovascular disease in survivors of childhood cancer. ©2020 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33033146      PMCID: PMC7855495          DOI: 10.1158/1055-9965.EPI-20-0809

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.090


  33 in total

1.  Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report.

Authors: 
Journal:  Pediatrics       Date:  2011-11-14       Impact factor: 7.124

Review 2.  Approach for Classification and Severity Grading of Long-term and Late-Onset Health Events among Childhood Cancer Survivors in the St. Jude Lifetime Cohort.

Authors:  Melissa M Hudson; Matthew J Ehrhardt; Nickhill Bhakta; Malek Baassiri; Hesham Eissa; Wassim Chemaitilly; Daniel M Green; Daniel A Mulrooney; Gregory T Armstrong; Tara M Brinkman; James L Klosky; Kevin R Krull; Noah D Sabin; Carmen L Wilson; I-Chan Huang; Johnnie K Bass; Karen Hale; Sue Kaste; Raja B Khan; Deo Kumar Srivastava; Yutaka Yasui; Vijaya M Joshi; Saumini Srinivasan; Dennis Stokes; Mary Ellen Hoehn; Matthew Wilson; Kirsten K Ness; Leslie L Robison
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-12-29       Impact factor: 4.254

Review 3.  Global risk of coronary heart disease: assessment and application.

Authors:  Anthony J Viera; Stacey L Sheridan
Journal:  Am Fam Physician       Date:  2010-08-01       Impact factor: 3.292

4.  Racial Differences in 20-Year Cardiovascular Mortality Risk Among Childhood and Young Adult Cancer Survivors.

Authors:  Amy M Berkman; Abenaa M Brewster; Lee W Jones; Jun Yu; J Jack Lee; S Andrew Peng; Abigail Crocker; Joann L Ater; Susan C Gilchrist
Journal:  J Adolesc Young Adult Oncol       Date:  2017-05-22       Impact factor: 2.223

5.  Maternal and paternal history of myocardial infarction and risk of cardiovascular disease in men and women.

Authors:  H D Sesso; I M Lee; J M Gaziano; K M Rexrode; R J Glynn; J E Buring
Journal:  Circulation       Date:  2001-07-24       Impact factor: 29.690

6.  Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer.

Authors:  S E Lipshultz; S R Lipsitz; S M Mone; A M Goorin; S E Sallan; S P Sanders; E J Orav; R D Gelber; S D Colan
Journal:  N Engl J Med       Date:  1995-06-29       Impact factor: 91.245

7.  Clinical ascertainment of health outcomes among adults treated for childhood cancer.

Authors:  Melissa M Hudson; Kirsten K Ness; James G Gurney; Daniel A Mulrooney; Wassim Chemaitilly; Kevin R Krull; Daniel M Green; Gregory T Armstrong; Kerri A Nottage; Kendra E Jones; Charles A Sklar; Deo Kumar Srivastava; Leslie L Robison
Journal:  JAMA       Date:  2013-06-12       Impact factor: 56.272

8.  Perceptions of future health and cancer risk in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study.

Authors:  Todd M Gibson; Chenghong Li; Gregory T Armstrong; Deo Kumar Srivastava; Wendy M Leisenring; Ann Mertens; Tara M Brinkman; Lisa Diller; Paul C Nathan; Melissa M Hudson; Leslie L Robison
Journal:  Cancer       Date:  2018-06-25       Impact factor: 6.860

9.  Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort.

Authors:  Daniel A Mulrooney; Mark W Yeazel; Toana Kawashima; Ann C Mertens; Pauline Mitby; Marilyn Stovall; Sarah S Donaldson; Daniel M Green; Charles A Sklar; Leslie L Robison; Wendy M Leisenring
Journal:  BMJ       Date:  2009-12-08

10.  Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study.

Authors:  Ann C Mertens; Qi Liu; Joseph P Neglia; Karen Wasilewski; Wendy Leisenring; Gregory T Armstrong; Leslie L Robison; Yutaka Yasui
Journal:  J Natl Cancer Inst       Date:  2008-09-23       Impact factor: 11.816

View more
  1 in total

1.  Risk of Cardiometabolic Risk Factors in Women With and Without a History of Breast Cancer: The Pathways Heart Study.

Authors:  Marilyn L Kwan; Richard K Cheng; Carlos Iribarren; Romain Neugebauer; Jamal S Rana; Mai Nguyen-Huynh; Zaixing Shi; Cecile A Laurent; Valerie S Lee; Janise M Roh; Hanjie Shen; Eileen Rillamas-Sun; Margarita Santiago-Torres; Dawn L Hershman; Lawrence H Kushi; Heather Greenlee
Journal:  J Clin Oncol       Date:  2022-01-13       Impact factor: 50.717

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.